Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2.

view more →

Their clinical research software accelerates timelines by automating multiple high impact processes.

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI

view more →

Code Bio is a preclinical stage company developing novel genetic medicines.

view more →

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

view more →

Gozio promotes loyalty and growth for a health system by creating a system-specific app that enhances the patient experience.

view more →

Huma.ai is a next-generation low code/no code data science solution for the life sciences industry.

view more →

IMMvention is developing novel, first-in-class therapies for treating hemolytic anemias.

view more →

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

view more →

We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles.

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

view more →

Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases.